Financials
Income statement
Fiscal date | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 |
---|---|---|---|---|
Total reported revenue | 19.9B | 19.5B | 20.2B | 19.4B |
Cost of revenue | 16.2B | 15.8B | 16.4B | 15.5B |
Gross profit | 3.7B | 3.7B | 3.8B | 3.8B |
Operating expense | ||||
Research & development | 352M | 351M | 335M | 349M |
Selling general and admin | 722M | 684M | 705M | 671M |
Other operating expenses | 629M | 632M | 630M | 676M |
Operating income | 1.1B | 1.2B | 1.3B | 1.3B |
Non operating interest income | ||||
Income | 11M | 7M | 4M | 0 |
Expense | 8M | 4M | 4M | 5M |
Other income expense | — | — | — | — |
Pretax income | 2.2B | 1.2B | 1.3B | 1.4B |
Tax provision | 628M | 302M | 273M | 353M |
Net income | 1.6B | 857M | 1.0B | 999M |
Basic EPS | — | 70.8 | — | — |
Diluted EPS | — | 70.8 | — | — |
Basic average shares | — | 12.1M | — | — |
Diluted average shares | — | 12.1M | — | — |
EBITDA | 1.4B | 1.4B | 1.4B | 1.5B |
Net income from continuing op. | — | — | — | — |
Minority interests | -1M | 0 | -1M | 0 |
Preferred stock dividends | 0 | 0 | 0 | 0 |